Filter by condition:
- Abilify
- Amitriptyline
- Amoxapine
- Anafranil
- Antabuse
- Aripiprazole
- Atomoxetine Hydrochloride
- AVENTYL
- Brintellix
- Bupropion Hcl
- Bupropion SR
- Bupropion XL
- Buspirone Hydrochloride
- Campral
- Carbolith
- Celexa
- Chlorpromazine Hydrochloride
- Cipralex
- Citalopram
- Citalopram Hydrobromide
- Clomipramine Hydrochloride
- Clopixol Acuphase
- Clopixol Depot
- Cymbalta
- Desipramine Hydrochloride
- Desvenlafaxine Succinate
- Desyrel
- Disulfiram
- Dormer
- Dothiepin
- Duloxetine
- Edronax
- Efexor
- Effexor
- Elavil
- Escitalopram
- Fetzima
- Fluanxol
- Fluoxetine
- Flupentixol
- Fluphenazine Hcl
- Fluphenazine Hydrochloride
- Fluvoxamine
- Geodon
- Haloperidol
- Hydroxyzine Hydrochloride
- Iloperidone
- Imipramine Hydrochloride
Most Searched Mental health medications for U.S. Patients
Direct access to the most frequently prescribed U.S. medications across all pages of mental health medications:
- Lexapro(Escitalopram Oxalate)
- Wellbutrin XL(Bupropion Hydrochloride XL)
- Zoloft(Sertraline)
- Prozac(Fluoxetine)
- Trintellix(Vortioxetine)
- Vraylar(Cariprazine)
- Rexulti(Brexpiprazole)
- Cymbalta(Duloxetine HCl)
- Pristiq(Desvenlafaxine Succinate)
- Viibryd(Vilazodone Hydrochloride)
- Abilify(Aripiprazole)
- Seroquel(Quetiapine Fumarate)
- Lamictal(Lamotrigine)
- Effexor(Venlafaxine)
Drug Classes & How They Work
- Clinical guidelines from the American Psychiatric Association (APA) and the Canadian Network for Mood and Anxiety Treatments (CANMAT) classify psychiatric medications by their primary receptor and transporter affinities (1.1) (2.1) (4.1).
| Pharmacological Class | Representative Active Ingredients | Primary Neurochemical Mechanism | Primary Indications & Clinical Notes |
|---|---|---|---|
| Selective serotonin reuptake inhibitors (SSRIs) | Escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), paroxetine, citalopram, fluvoxamine | Selectively inhibits presynaptic SERT serotonin reuptake transporter | First-line therapy for MDD, GAD, panic disorder, OCD, and PTSD; favorable cardiovascular safety profile (1.1) (2.1) |
| Serotonin-norepinephrine reuptake inhibitors (SNRIs) | Venlafaxine XR (Effexor XR), desvenlafaxine (Pristiq), duloxetine (Cymbalta), levomilnacipran | Dual inhibition of presynaptic serotonin (SERT) and norepinephrine (NET) transporters | MDD, GAD, social anxiety, plus diabetic peripheral neuropathic pain and fibromyalgia (duloxetine); monitor blood pressure (1.1) (2.1) |
| Multimodal & atypical antidepressants | Vortioxetine (Trintellix), bupropion XL/SR (Wellbutrin), mirtazapine (Remeron), trazodone | Direct 5-HT receptor modulation + SERT inhibition (vortioxetine); NDRI (bupropion); alpha-2 antagonist (mirtazapine) | MDD, seasonal affective disorder, or adjunctive therapy; bupropion has minimal sexual dysfunction or weight gain (1.1) (3.1) |
| Second-generation (atypical) antipsychotics | Aripiprazole (Abilify), lurasidone (Latuda), quetiapine (Seroquel), risperidone, olanzapine, brexpiprazole (Rexulti) | Dopamine D2/5-HT1A partial agonism or D2/5-HT2A receptor antagonism | Schizophrenia, bipolar mania/depression, and adjunctive treatment of major depressive disorder (2.1) (3.1) |
| Mood stabilizers & non-benzodiazepine anxiolytics | Lamotrigine (Lamictal), lithium carbonate, buspirone | Voltage-gated sodium channel modulation (lamotrigine); 5-HT1A partial agonism (buspirone) | Bipolar maintenance prophylaxis (lamotrigine, lithium); chronic generalized anxiety without physical dependence (buspirone) (1.1) (2.1) |
Mental health medications: Clinical Overview & Scope
Psychopharmacological medications modulate central nervous system neurotransmission, primarily serotonin (5-HT), norepinephrine, dopamine, glutamate, and gamma-aminobutyric acid (GABA) signaling pathways, to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar spectrum disorders, and schizophrenia (1.1) (2.1).
Because adaptive receptor downregulation and neurotrophic synaptic remodeling (such as brain-derived neurotrophic factor expression) develop gradually, most maintenance antidepressants require 4 to 8 weeks of consistent daily dosing to achieve full therapeutic remission (1.1) (3.1).
Representative medications in our mental health medications directory include Abilify (Aripiprazole), Amitriptyline (Generic), Amoxapine (Generic), Anafranil (Clomipramine Hydrochloride), Antabuse (Disulfiram), Aripiprazole (Generic), Atomoxetine Hydrochloride (Generic), AVENTYL (Nortriptyline), among 109 total listings in this category (1.1).
Dosage Forms, Release Profiles & Devices
- Extended-release psychiatric formulations are engineered to minimize peak-to-trough plasma concentration swings and prevent inter-dose withdrawal symptoms (2.1) (3.1).
- For example, bupropion is manufactured in immediate-release (dosed three times daily), sustained-release (SR, dosed twice daily), and extended-release (XL, dosed once daily) tablets; because high peak plasma concentrations of bupropion increase seizure risk, XL and SR tablets must be swallowed whole and are not interchangeable without a prescriber order (2.1).
- Similarly, venlafaxine XR and duloxetine use enteric-coated spheroids inside a capsule to control dissolution and prevent gastric irritation (2.1).
- Certain atypical antipsychotics have specific nutritional absorption requirements: lurasidone (Latuda) must be taken with a meal containing at least 350 calories to double its oral absorption (2.1) (4.1).
Key Safety, Storage & Monitoring Points
- All antidepressants carry an FDA and Health Canada boxed warning regarding an increased risk of suicidal ideation and behavior in children, adolescents, and young adults (up to age 24) during the initial months of therapy or following dose adjustments (2.1) (4.1).
- Combining serotonergic antidepressants (SSRIs, SNRIs, vortioxetine, tricyclics) with monoamine oxidase inhibitors (MAOIs), linezolid, triptans, or St (3.1).
- John's wort can precipitate life-threatening serotonin syndrome, characterized by clonus, hyperreflexia, autonomic instability, and hyperthermia (1.1) (2.1).
- Antidepressants, particularly short-half-life agents such as paroxetine and venlafaxine, must never be stopped abruptly; gradual dose tapering under medical supervision prevents antidepressant discontinuation syndrome (dizziness, paresthesias, insomnia, and rebound anxiety) (1.1) (3.1).
- Patients on second-generation antipsychotics require periodic metabolic monitoring of fasting glucose, lipid panels, and weight (2.1) (3.1).
Ordering & Prescription Checklist for U.S. Patients
- Match your prescription details: Confirm the active ingredient name, exact milligram or microgram strength, release profile, and package quantity on your U.S. prescription (2.1) (4.1).
- Licensed pharmacist review: Every order undergoes a dosing, strength, and drug-interaction check in under 1 business day, followed by a mandatory pharmacist consultation before dispatch (3.1).
- Transparent USD pricing and shipping: Room-temperature medications ship for $14.99 USD flat rate and cold-chain medications ship in $29.99 USD insulated coolers via tracked Canada Post and USPS delivery.
- Need help matching a product or transferring an Rx? Call 1-888-868-1920 (Monday - Friday: 9:00AM - 6:00PM; Saturday - Sunday: Closed) or review our step-by-step ordering guide and prescription requirements.
Frequently Asked Questions
Why must lurasidone (Latuda) be taken with a meal of at least 350 calories?
Lurasidone has food-dependent gastrointestinal solubility; taking it with at least 350 calories of food increases total drug exposure (AUC) roughly twofold and peak concentration threefold compared to fasting conditions (2.1). Taking it on an empty stomach can lead to subtherapeutic blood levels.
What is the difference between Wellbutrin SR and Wellbutrin XL?
Why should SSRIs and SNRIs be tapered gradually rather than stopped suddenly?
Abrupt cessation of serotonergic medications, especially shorter-half-life agents like venlafaxine or paroxetine, causes a rapid drop in synaptic serotonin availability, leading to discontinuation symptoms such as dizziness, sensory disturbances, nausea, and sleep disruption (1.1) (3.1). A clinician-guided taper allows receptors to readjust smoothly.
Related Medical Conditions
Related Practical Comparison Guides
References & Official Clinical Sources
Pharmacological classifications, mechanism comparisons, dosing-form distinctions, and clinical safety notes for mental health medications are compiled from official regulatory prescribing monographs and medical practice guidelines:
- (1.1) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults, Canadian Journal of Psychiatry (CANMAT).
- (2.1) Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts, American Psychological Association / Psychiatric Guidelines.
- (3.1) DailyMed: FDA Prescribing Information for Antidepressants, Mood Stabilizers, and Atypical Antipsychotics, U.S. National Library of Medicine / FDA.
- (4.1) MedlinePlus Mental Health Medications Overview, National Institute of Mental Health (NIH).
Need help finding your medication? Call 1-888-868-1920.